BIODESIX INC
Industry: Biotechnology (See others in industry)
Address:
2970 Wilderness Place Suite 100
Boulder, CO, 80301
Phone: 303-417-0500
Boulder, CO, 80301
Phone: 303-417-0500
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2020-10-01 | Amended | $16,000,000 | $12,958,471 | Other | 06b | SEC link |
| 2019-12-20 | New | $3,041,529 | $3,041,529 | Other | 06b | SEC link |
| 2019-08-22 | New | $4,902,500 | $4,902,500 | Other | 06b | SEC link |
| 2018-10-23 | New | $17,511,736 | $17,511,736 | Equity Only | 06b | SEC link |
| 2018-07-18 | Amended | $7,987,428 | $0 | Equity Only | 06b | SEC link |
| 2018-07-16 | New | $7,987,428 | $7,987,428 | Equity Only | 06b | SEC link |
| 2018-05-08 | New | $5,282,162 | $5,282,162 | Other | 06b | SEC link |
| 2018-03-09 | New | $1,500,000 | $1,500,000 | Equity Only | 06b | SEC link |
| 2017-04-24 | New | $13,165,482 | $13,165,482 | Equity Only | 06b | SEC link |
| 2016-11-30 | New | $5,121,632 | $5,121,632 | Other | 06b | SEC link |
| 2016-07-27 | New | $6,114,729 | $6,114,729 | Equity Only | 06b | SEC link |
| 2016-02-12 | New | $17,756,512 | $17,756,512 | Equity Only | 06b | SEC link |
| 2015-10-08 | New | $8,609,000 | $8,609,000 | Other | 06b | SEC link |
| 2015-06-23 | New | $10,390,000 | $10,390,000 | Equity Only | 06b | SEC link |
| 2015-01-13 | New | $11,285,000 | $11,285,000 | Equity Only | 06b | SEC link |
| 2014-01-13 | Amended | $14,407,686 | $6,085,896 | Equity Only | 06b | SEC link |
| 2013-12-03 | New | $8,321,790 | $8,321,790 | Equity Only | 06b | SEC link |
| 2013-10-22 | New | $4,011,400 | $4,011,400 | Other | 06b | SEC link |
| 2013-04-11 | New | $7,313,440 | $7,313,440 | Equity Only | 06 | SEC link |
| 2012-09-04 | New | $5,685,500 | $5,685,500 | Equity Only | 06 | SEC link |
| 2011-07-05 | New | $10,000,000 | $10,000,000 | Equity Only | 06 | SEC link |
| 2010-10-28 | New | $3,536,232 | $3,536,232 | Equity Only | 06 | SEC link |
| 2009-10-23 | Amended | $4,799,980 | Unknown | Equity Only | 06 | SEC link |
| 2009-09-28 | New | $4,500,000 | Unknown | Equity Only | 06 | SEC link |
| 2008-09-02 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2008-09-02 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2008-09-02 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2008-09-02 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2008-09-02 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2008-07-08 | Paper Filing | Unknown | Unknown | Other | Not Available |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Paul Beresford, Ph.D. | Executive |
| Wendy Blosser | Executive |
| David Brunel | Director |
| Robert Cawthorn | Director |
| Bobbi Coffin | Executive |
| Robin Cowie | Executive |
| Liz Fliegelman | Executive |
| Jean Franchi | Director |
| Robert Georgantas | Executive |
| Scott Hutton | Director, Executive |
| Hany Massarany | Director |
| Mark Miller | Director |
| John Patience | Director |
| Gary Pestano, Ph.D. | Executive |
| Jim Purvis | Executive |
| Heinrich Roder | Director, Executive |
| Heinrich Roder, D.Phil | Executive |
| Heinrich Roder, D.Phil. | Executive |
| Frank Ronchetti | Executive |
| Jack Schuler | Director |
| Matt Stauffer | Executive |
| Matthew Strobeck | Director |
| Linda Traylor, Ph.D. | Executive |
| Charles Watts | Director |